Clinical Trial Update: Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib

View source ↗

Summary

This clinical trial update describes a real-world participant experience study of Vimseltinib for Tenosynovial Giant Cell Tumor, with the study currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tenosynovial Giant Cell Tumor

Drugs mentioned

• Vimseltinib (Vimseltinib)

Snippet

Sponsor: Deciphera Pharmaceuticals, LLC | Conditions: Tenosynovial Giant Cell Tumor | Status: RECRUITING